Telesis Bio Inc.
TBIODelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850079
Telesis Bio Inc. was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Jul 26, 2024; 21 institutions reported holding it in 13F filings for Q1 2024, worth $4.77M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Telesis Bio Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +2 vs. Q4 2022
- Shares held
- 12.0M
- −484.2K (−3.9%) vs. Q4 2022
- Total value
- $37.3M
- +$22.2M (+146.9%) vs. Q4 2022
- New holders
- 4
- 6 more added
- Sold out
- 2
- 10 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $178.5K |
| Q2 2024 | 10 | $2.05M |
| Q1 2024 | 21 | $4.77M |
| Q4 2023 | 26 | $4.50M |
| Q3 2023 | 26 | $12.3M |
| Q2 2023 | 30 | $18.9M |
| Q1 2023 | 28 | $37.3M |
| Q4 2022 | 26 | $15.1M |
| Q3 2022 | 33 | $20.9M |
| Q2 2022 | 39 | $26.1M |
| Q1 2022 | 47 | $92.9M |
| Q4 2021 | 43 | $186.8M |
| Q3 2021 | 43 | $76.8M |
| Q2 2021 | 40 | $138.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Telesis Bio Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 3 | $0 | 0.00% | −1−25.0% | Reduced |
| Citigroup Inc | 6 | $19 | 0.00% | −158−96.3% | Reduced |
| Citadel Advisors LLC | 20 | $62 | 0.00% | +20 | New |
| Wells Fargo & Company | 61 | $189 | 0.00% | +1+1.7% | Added |
| Advisor Group Holdings, Inc. | 225 | $697 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 272 | $843 | 0.00% | −3,474−92.7% | Reduced |
| JPMorgan Chase & Co | 510 | $2.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2,275 | $7.05K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,961 | $12.0K | 0.00% | −4,982−55.7% | Reduced |
| Morgan Stanley | 5,106 | $15.8K | 0.00% | +3,463+210.8% | Added |
| Simplex Trading, LLC | 5,535 | $17.0K | 0.00% | −165−2.9% | Reduced |
| Bank of America Corp | 6,000 | $18.6K | 0.00% | −22−0.4% | Reduced |
| Two Sigma Securities, LLC | 10,515 | $32.6K | 0.00% | +10,515 | New |
| Northern Trust Corp | 15,937 | $49.4K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 18,600 | $57.7K | 0.00% | +18,600 | New |
| State Street Corp | 21,800 | $67.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 22,950 | $71.1K | 0.00% | −21,382−48.2% | Reduced |
| BlackRock Inc. | 24,694 | $76.6K | 0.00% | −3,115−11.2% | Reduced |
| Susquehanna International Group, LLP | 42,375 | $131.4K | 0.00% | +27,639+187.6% | Added |
| Vontobel Holding Ltd. | 50,000 | $155.0K | 0.00% | +50,000 | New |
| Geode Capital Management, LLC | 72,811 | $225.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 95,394 | $296.0K | 0.00% | +14,294+17.6% | Added |
| Bridgeway Capital Management, LLC | 117,000 | $362.7K | 0.01% | 00.0% | Unchanged |
| Penbrook Management LLC | 342,470 | $1.06M | 0.83% | +73,620+27.4% | Added |
| Millennium Management LLC | 344,051 | $1.07M | 0.00% | −12,792−3.6% | Reduced |
| Vanguard Group Inc | 427,202 | $1.32M | 0.00% | +16,938+4.1% | Added |
| Penn Capital Management Co Inc | 544,283 | $1.69M | 0.17% | −629,779−53.6% | Reduced |
| Northpond Ventures, LLC | 9,844,130 | $30.5M | 17.44% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,397−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −3−100.0% | Sold out |